ResourcesBlogs
Muna Bhanji joins the Synthio Labs Pharma Leaders Advisory Council

Muna Bhanji joins the Synthio Labs Pharma Leaders Advisory Council

Ketaki Kakade, Head of Growth

Synthio Labs welcomes Muna Bhanji to its Pharma Leaders Advisory Council.

Synthio Labs welcomes Muna Bhanji to its Pharma Leaders Advisory Council. Muna is a former Merck executive where she served as Senior Vice President, Global Market Access and Policy, responsible for the pricing and market access strategy for the company's global portfolio of medicines and vaccines.

Muna currently serves in various senior advisory roles within the healthcare and technology sectors as well as serving on the boards of Cytokinetics, Ardelyx, Intellia Therapeutics and Veracyte.

“A medicine’s impact depends on what happens after approval: how physicians learn about it, how payers weigh its value, and how patients get access to it.

AI is enabling pharma companies to reimagine how their marketing, market access and medical teams can work together to uncover deeper insights, drive efficiency and effectiveness in support of patient access. Synthio is building for that shift, and I’m excited to be a thought partner to the team.”

Muna Bhanji Member, Pharma Leaders’ Advisory Council, Synthio Labs

‍

The Pharma Leaders Advisory Council is composed of senior executives who have led major transformations across the pharma industry. The advisors bring that experience to Synthio Labs, advising on the industry's strategic direction and on the responsible adoption of AI across pharma. Synthio builds clinical-grade voice and agentic AI for pharma commercial and medical teams, and the council ensures these technology solutions are shaped by leaders who understand the industry's responsibility to physicians and patients.

“Muna has spent her career on the question every new medicine eventually faces: how does it reach the patients who need it?

She led market access for one of the largest portfolios in the industry, and she knows what commercial and market access teams need to see before they trust a new technology. Her perspective will shape how we build for the teams bringing medicines to physicians and patients, and we’re honored to have her on the council.”

Supreet Deshpande CEO & Cofounder, Synthio Labs

Muna Bhanji joins the Synthio Labs Pharma Leaders Advisory Council

Ketaki Kakade, Head of Growth
Oct 1, 2026

Heading

Increase in patient engagement

Heading

Reduction in appointment cancellations

Heading

Improvement in treatment adherence

Synthio Labs welcomes Muna Bhanji to its Pharma Leaders Advisory Council. Muna is a former Merck executive where she served as Senior Vice President, Global Market Access and Policy, responsible for the pricing and market access strategy for the company's global portfolio of medicines and vaccines.

Muna currently serves in various senior advisory roles within the healthcare and technology sectors as well as serving on the boards of Cytokinetics, Ardelyx, Intellia Therapeutics and Veracyte.

“A medicine’s impact depends on what happens after approval: how physicians learn about it, how payers weigh its value, and how patients get access to it.

AI is enabling pharma companies to reimagine how their marketing, market access and medical teams can work together to uncover deeper insights, drive efficiency and effectiveness in support of patient access. Synthio is building for that shift, and I’m excited to be a thought partner to the team.”

Muna Bhanji Member, Pharma Leaders’ Advisory Council, Synthio Labs

‍

The Pharma Leaders Advisory Council is composed of senior executives who have led major transformations across the pharma industry. The advisors bring that experience to Synthio Labs, advising on the industry's strategic direction and on the responsible adoption of AI across pharma. Synthio builds clinical-grade voice and agentic AI for pharma commercial and medical teams, and the council ensures these technology solutions are shaped by leaders who understand the industry's responsibility to physicians and patients.

“Muna has spent her career on the question every new medicine eventually faces: how does it reach the patients who need it?

She led market access for one of the largest portfolios in the industry, and she knows what commercial and market access teams need to see before they trust a new technology. Her perspective will shape how we build for the teams bringing medicines to physicians and patients, and we’re honored to have her on the council.”

Supreet Deshpande CEO & Cofounder, Synthio Labs

Download icon with a downward arrow pointing to a horizontal line inside a blue circular button.

Thank you! The case study will be emailed to you shortly. Please check your spam and junk folders

Oops! Something went wrong while submitting the form.
Download icon with a downward arrow pointing to a horizontal line inside a blue circular button.

Thank you! The case study will be emailed to you shortly. Please check your spam and junk folders

Oops! Something went wrong while submitting the form.